通过编程细胞死亡对瘤树突细胞的调节 1 途径
1Mayo Clinic, Jacksonville, FL.
Journal of immunology (Baltimore, Md. : 1950)
|April 15, 2024
概括
像PD-1/PD-L1疗法这样的免疫检查点抑制剂在癌症治疗中表现有前途,但并非所有患者都能反应. 这篇评论探讨了这些途径如何调节树突细胞,并建议新的组合疗法以获得更好的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫检查点阻塞疗法,包括抗PD-1/PD-L1,已经改变了癌症治疗,降低死亡率.
- 尽管取得了成功,但许多患者对这些疗法没有反应,需要对抗性机制进行研究.
研究的目的:
- 审查最近关于PD-1,PD-L1和PD-L2在调节质细胞功能中的瘤微环境中的作用的发现.
- 为了突出这一免疫调节轴对瘤透的树突细胞的影响.
主要方法:
- 关于免疫检查点和髓状细胞活动的最新研究的文献综述.
- 对PD-1,PD-L1和PD-L2在瘤微环境中的调节作用的分析.
主要成果:
- PD-1/PD-L1通路超出T细胞调节范围,直接影响髓状细胞活动.
- 瘤透的树突细胞受到这种免疫调节轴的显著调节.
结论:
- 需要进一步的机制研究来阐明PD-1,PD-L1和PD-L2在树突细胞功能中的确切作用.
- 这些知识可以指导新型组合免疫疗法的开发,以提高治疗效率并使更多的癌症患者受益.
相关概念视频
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cytotoxic T Cells-mediated Immune Response
904
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904
Overview of Cell Death
7.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.3K


